fidarestat has been researched along with deoxyguanosine in 2 studies
| Studies (fidarestat) | Trials (fidarestat) | Recent Studies (post-2010) (fidarestat) | Studies (deoxyguanosine) | Trials (deoxyguanosine) | Recent Studies (post-2010) (deoxyguanosine) |
|---|---|---|---|---|---|
| 97 | 3 | 33 | 6,470 | 225 | 2,167 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyasita, Y; Oyama, T; Shirai, K; Watanabe, H | 1 |
| Kato, N; Kihara, M; Kusunoki, S; Kuzumoto, Y; Low, PA | 1 |
2 other study(ies) available for fidarestat and deoxyguanosine
| Article | Year |
|---|---|
The role of polyol pathway in high glucose-induced endothelial cell damages.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehyde Reductase; Carbohydrate Metabolism; Caspase 3; Cells, Cultured; Culture Media; Deoxyguanosine; DNA Fragmentation; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Glucose; Humans; Imidazolidines; Polymers; Signal Transduction; Sorbitol | 2006 |
Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehyde Reductase; Animals; Blood Flow Velocity; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Glutathione; Imidazolidines; Male; Mice; Neurons; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2006 |